Your new post is loading...
Blood Cancer Journal is a peer-reviewed, open access online journal publishing pre-clinical and clinical work in the field of hematology with ramifications into translational biology research down to new therapies...
Via Krishan Maggon
|
Rescooped by Gilbert C FAURE from Cancer Pathways inhibitors Collection |
Scoop.it!
Via Krishan Maggon
Citation: Blood Cancer Journal (2015) 5, e309; doi:10.1038/bcj.2015.30
Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testingPublished online 1 May 2015
OPEN
P O Pietarinen1, T Pemovska2, M Kontro1, B Yadav2, J P Mpindi2, E I Andersson1, M M Majumder2, H Kuusanmäki2, P Koskenvesa1, O Kallioniemi2, K Wennerberg2, C A Heckman2, S Mustjoki1,3 and K Porkka1,3
Correspondence: Dr K Porkka, Division of Hematology, Department of Medicine, Comprehensive Cancer Center, Helsinki University Hospital, University of Helsinki, PO Box 372, Haartmaninkatu 4, FIN-00290 Helsinki, Finland. E-mail: Kimmo.porkka@helsinki.fi